FRA, ANNAMARIA
 Distribuzione geografica
Continente #
NA - Nord America 4.739
EU - Europa 2.402
AS - Asia 2.182
SA - Sud America 366
Continente sconosciuto - Info sul continente non disponibili 249
AF - Africa 49
OC - Oceania 9
Totale 9.996
Nazione #
US - Stati Uniti d'America 4.640
CN - Cina 742
SG - Singapore 741
PL - Polonia 631
IT - Italia 413
UA - Ucraina 323
BR - Brasile 295
DE - Germania 256
GB - Regno Unito 247
HK - Hong Kong 219
FI - Finlandia 151
VN - Vietnam 141
FR - Francia 97
TR - Turchia 90
RU - Federazione Russa 78
BD - Bangladesh 73
IE - Irlanda 68
IN - India 66
CA - Canada 44
MX - Messico 34
BE - Belgio 24
SE - Svezia 24
AR - Argentina 23
JP - Giappone 19
NL - Olanda 17
VE - Venezuela 17
ES - Italia 16
ZA - Sudafrica 16
CH - Svizzera 14
ID - Indonesia 12
PK - Pakistan 12
IQ - Iraq 11
AU - Australia 9
AT - Austria 8
EC - Ecuador 8
LT - Lituania 8
NG - Nigeria 8
CO - Colombia 7
JM - Giamaica 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
PY - Paraguay 6
AZ - Azerbaigian 5
DZ - Algeria 5
EU - Europa 5
JO - Giordania 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
EG - Egitto 4
KE - Kenya 4
PE - Perù 4
PT - Portogallo 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
CL - Cile 3
DK - Danimarca 3
HN - Honduras 3
MU - Mauritius 3
RO - Romania 3
BG - Bulgaria 2
BY - Bielorussia 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
MA - Marocco 2
MY - Malesia 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
SN - Senegal 2
AL - Albania 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.753
Città #
Warsaw 630
Fairfield 452
Singapore 438
Ashburn 419
Woodbridge 289
Jacksonville 237
Chandler 217
Hong Kong 215
Wilmington 199
Houston 197
Ann Arbor 192
Cambridge 192
Beijing 191
San Jose 189
Seattle 189
The Dalles 125
Brescia 113
New York 113
Princeton 112
Lancaster 102
Los Angeles 92
Helsinki 80
Chicago 74
Nanjing 74
Dearborn 67
Dublin 67
Munich 61
Lauterbourg 60
Istanbul 59
Buffalo 50
Council Bluffs 50
Columbus 48
Des Moines 46
Ho Chi Minh City 46
Rome 40
San Diego 33
San Francisco 32
Shanghai 31
Dallas 29
Nanchang 29
Dong Ket 28
Milan 28
São Paulo 27
London 26
Changsha 25
Moscow 25
Tianjin 24
Turku 24
Brussels 23
Hanoi 23
Jiaxing 23
Orem 23
Redondo Beach 23
Indianapolis 21
Santa Clara 21
Shenyang 21
Salt Lake City 20
Hebei 18
Jinan 18
Phoenix 17
Tampa 17
Brooklyn 16
Tokyo 16
Elk Grove Village 15
Boston 14
Guangzhou 14
Kocaeli 14
Hangzhou 12
Lappeenranta 12
Montreal 12
Rio de Janeiro 12
Denver 11
Frankfurt am Main 11
Jakarta 11
Kunming 11
Manchester 11
Atlanta 10
Boardman 10
Chennai 10
Lugano 10
Miami 10
St Louis 10
Toronto 10
Zhengzhou 10
Charlotte 9
Johannesburg 9
Mexico City 9
Mooresville 9
Nuremberg 9
Pune 9
Saratoga Springs 9
Abuja 8
Belo Horizonte 8
Lanzhou 8
Poplar 8
Verona 8
Naples 7
Orange 7
Taizhou 7
Ankara 6
Totale 6.756
Nome #
The pathological Trento variant of alpha-1-antitrypsin (E75V) shows non-classical behaviour during polymerization 316
Human iPSC-Derived 3D Hepatic Organoids in a Miniaturized Dynamic Culture System 273
Cysteines as Redox Molecular Switches and Targets of Disease 273
Intermittent C1-Inhibitor Deficiency Associated with Recessive Inheritance: Functional and Structural Insight 267
Characterisation of a type II functionally-deficient variant of alpha-1-antitrypsin discovered in the general population 254
Stability and structural change in the pathological polymerisation of alpha 1-antitrypsin 206
Different molecular behavior of CD40 mutants causing hyper-IgM syndrome. 204
Quality control of ER synthesized proteins: an exposed thiol group as a three-way switch mediating assembly, retention and degradation 200
Developmental regulation of IgM secretion: the role of the carboxy-terminal cysteine 193
Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency 191
Identification and characterisation of eight novel SERPINA1 null mutations. 190
Development of a novel assay to measure alpha-1-antitrypsin inhibitory activity toward neutrophil elastase 184
Functional characterization of amino acid variants of the reactive-center-loop of alpha-1-antitrypsin 182
Characterization of a mouse endothelium lymphatic cell line. 181
Cellular models for the serpinopathies 181
Aberrant disulphide bonding contributes to the ER retention of alpha1-antitrypsin deficiency variants 178
A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface 177
Caveolin-1 and -2 in the exocytic pathway of MDCK cells 172
The Decrease of Mineralcorticoid Receptor Drives Angiogenic Pathways in Colorectal Cancer 171
Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6 170
Alpha1-antitrypsin deficiency: a twenty-five years' experience. 167
Degradation of unassembled soluble Ig subunits by cytosolic proteasomes: evidence that retrotranslocation and degradation are coupled events 164
De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin 162
Intrahepatic heteropolymerization of M and Z alpha-1-antitrypsin 161
Phenotypic behavior of C2C12 myoblasts upon expression of the dystrophy-related caveolin-3 P104L and TFT mutants 156
Molecular characterization of the new defective P(brescia) alpha1-antitrypsin allele. 156
Exposed thiols confer localization in the endoplasmic reticulum by retention rather than retrieval 155
CHOP-independent apoptosis and pathway-selective induction of the UPR in developing plasma cells 151
Molecular characterization of new variants associated with alpha-1-antitrypsin deficiency (AATD) 151
Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization. 148
Fab fragment of an antibody selective for wild-type alpha-1-antitrypsin in complex with its antigen 145
Fab fragment of an antibody selective for wild-type alpha-1-antitrypsin 144
Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor 144
A case of remittent C1-inhibitor deficiency 143
Progressively impaired proteasomal capacity during terminal plasma cell differentiation 139
Aberrant disulphide interactions contribute to the secretory deficiency of Alpha 1-Antitrypsin mutants 135
Generation and characterization of a mouse lymphatic endothelial cell line 134
The endoplasmic reticulum as a site of protein degradation 132
The efficiency of cysteine-mediated intracellular retention determines the differential fate of secretory IgA and IgM in B and plasma cells 128
Human caveolin-1 and caveolin-2 are closely linked genes colocalized with WI-5336 in a region of 7q31 frequently deleted in tumors 127
Patogenesi delle malattie da alterato trasporto e accumulo proteico nella via secretoria 127
Mechanisms of interleukin-6 protection against ischemia-reperfusion injury in rat liver 127
Characterization of alpha-1 antitrypsin mutants with an alternative polymerisation mechanism 126
Genomic organization and transcriptional analysis of the human genes coding for caveolin-1 and caveolin-2 125
Assembly and secretion of antibodies during B cell development 123
Different mechanisms cause ER retention of rare alpha1-antitrypsin deficiency variants 122
Computational prediction of (alpha-1antitrypsin)-elastase Michaelis complex reveals an exosite contributing to high-affinity interaction 115
Identification of an exosite at the neutrophil elastase/alpha‐1‐antitrypsin interface 115
Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity 115
Comprehensive Clinical Diagnostic Pipelines Reveal New Variants in Alpha-1 Antitrypsin Deficiency 114
Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae 113
HIGM3 patients: understanding the mutation effect to develop a therapeutic approach 109
Structural characterisation of tissue-derived, disease-associated polymers of alpha-1-antitrypsin using conformation-selective antibodies and single-particle reconstructions from electron microscopy images 108
Modulating secretion of antibodies 106
Characterization of Novel Alpha-1-Antitrypsin Coding Variants in a Mammalian Cellular Model 104
Regolazione dei geni coinvolti nella patogenesi dell'angioedema ereditario da carenza di C1 inibitore 102
Quantification of circulating alpha-1-antitrypsin polymers in dried blood spots 101
Probing of the reactive center loop region of alpha-1-antitrypsin by mutagenesis predicts new type-2 dysfunctional variants 100
Polymers of Z α1-antitrypsin are secreted in cell models of disease 99
The molecular species responsible for α1 -antitrypsin deficiency are suppressed by a small molecule chaperone 95
Identification and characterisation of seven novel SERPINA1 null mutations 90
High-resolution characterization of ex vivo AAT polymers by solution-state NMR spectroscopy 89
The importance of N186 in the alpha-1-antitrypsin shutter region is revealed by the novel bologna deficiency variant 88
Quantification of circulating alpha-1-antitrypsin polymers associated with different SERPINA1 genotypes 87
Susceptibility of alpha-1 antitrypsin deficiency variants to polymer-blocking therapy 79
Identification and characterisation of twenty-two novel SERPINA1 pathological mutations 78
Clinical and molecular characterisation of new variants associated to alpha-1-antitrypsin deficiency 68
Neuroserpin: structure, function, physiology and pathology 66
Totale 9.996
Categoria #
all - tutte 43.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.923


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022492 0 94 14 16 6 28 43 37 21 98 35 100
2022/2023561 73 21 26 43 50 125 2 63 85 12 21 40
2023/2024521 39 14 41 43 26 102 20 27 114 15 11 69
2024/20251.603 18 13 14 151 175 124 145 45 139 91 455 233
2025/20262.642 288 276 165 359 308 182 424 106 170 185 118 61
2026/2027137 103 34 0 0 0 0 0 0 0 0 0 0
Totale 9.996